Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018

March 2014 | 237 pages | ID: P100B7BB87DEN
MarketsandMarkets

Abstracts

The global pediatric interventional cardiology market is a very dynamic market, as this market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was used for diagnostic purposes; however, currently, it is increasingly being used for treatment purposes as well. The transcatheter heart valve market is the fastest growing segment in the pediatric interventional cardiology market. In 2010, the first pediatric specific transcatheter pulmonary heart valve was launched in the U.S. market. Companies in this market are engaged in the development of new and improved transcatheter heart valves, which is a major reason for its high growth. In addition, this market is witnessing a number of venture capitalist investments, which is aiding in the development and launch of new products in this market.

In the coming years, the APAC and RoW regions are expected to grow at high CAGRs. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets in the pediatric interventional cardiology market. Both these regions offer a high growth potential as compared to mature markets such as Europe. Growth in these markets is spurred by the growing incidence of congenital heart disease (CHD). According to the American College of Cardiology Foundation, in 2010, the prevalence of CHD in Asia was 8.9 to 9.7 per 1,000 live births, whereas in Africa this figure was 1.1 to 3.5 per 1,000 live births. The APAC region is witnessing a number of collaborations between local players and foreign companies for the development of new products. Also, the APAC region is hosting a number of conferences and workshops for discussing new and advanced techniques that are present in the market. These conferences and workshops will help in stimulating innovation in the field of pediatric interventional cardiology, thus aiding the market to grow further.

The global pediatric interventional cardiology market is highly competitive and all the existing players in this market are engaged in developing new and advanced products, to maintain their market share. However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures are the factors that are likely to hinder the growth of this market. At present, difficulties encountered in clinical trials of pediatric medical devices such as patient recruitment and high cost are the major challenges faced by market players.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauze the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios and services offered by the top players in the pediatric interventional cardiology market. The report also provides the number of cath labs and the number of pediatric cardiology procedures performed across geographies
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pediatric interventional cardiology market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the promising applications of pediatric interventional cardiology devices across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pediatric interventional cardiology market
• Competitive Assessment: In depth assessment of market shares, strategies, products and services, distribution networks, manufacturing capabilities of leading players, and porters five forces analysis in the pediatric interventional cardiology market

Contents

1 INTRODUCTION

1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Scope
1.6 Research Methodology
  1.6.1 Market Size Estimation
  1.6.2 Market Crackdown & Data Triangulation
  1.6.3 Market Share Calculation
  1.6.4 Key Data Points from Primary Sources
  1.6.5 Key Data Points from Secondary Sources
  1.6.6 Assumptions

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

3.1 Investment Trends
3.2 Technology Trends
3.3 Regulatory Environment
  3.3.1 Regulatory Approval Procedures for Pediatric Cardiology Devices
    3.3.1.1 510(K) Application
    3.3.1.2 Premarket Approval (Pma) Application
    3.3.1.3 Humanitarian Device Exemption (Hde) Application
  3.3.2 Intellectual Property Protection and Patent Litigation
3.4 Reimbursement Scenario: Transcatheter Heart Valves
3.5 Porter’s Five Forces Analysis: Pediatric Interventional Cardiology Imaging Market
  3.5.1 Threat of New Entrants
  3.5.2 Bargaining Power of Suppliers
  3.5.3 Bargaining Power of Buyers
  3.5.4 Competitor Rivalry
  3.5.5 Threat of Substitutes
3.6 Unmet Need
  3.6.1 Pediatric-Specific Cardiac Devices
3.7 Winning Imperatives
  3.7.1 Investments in R&D Activities
  3.7.2 Acquisitions

4 MARKET OVERVIEW

4.1 Market Dynamics
  4.1.1 Market Drivers
    4.1.1.1 Pediatric Interventional Cardiology Devices
      4.1.1.1.1 Government Support, An Impetus for the Pediatric Interventional Cardiology Market
      4.1.1.1.2 Awareness Programs and Conferences to Fuel the Market
      4.1.1.1.3 Rising Incidences of Congenital Heart Defects(CHD)to Propel the Pediatric Interventional Cardiology Market
      4.1.1.1.4 Technological Advancements to Open New Opportunities for Device Manufacturers
      4.1.1.1.5 Advantages of Minimally Invasive Procedures Over Conventional Surgeries to Propel the Market Growth
    4.1.1.2 Pediatric Cardiology Imaging
      4.1.1.2.1 Fda’s Efforts to Bolster the Pediatric Cardiology Imaging Market
  4.1.2 Market Restraints
    4.1.2.1 Pediatric Interventional Cardiology Devices
      4.1.2.1.1 Complex Regulatory Procedures
      4.1.2.1.2 Varied Stringency of Regulatory Procedures Delays Product Launches
    4.1.2.2 Pediatric Cardiology Imaging
      4.1.2.2.1 Implementation of Excise Tax By the U.S. Government
  4.1.3 Market Opportunities
    4.1.3.1 Pediatric Interventional Cardiology Devices
      4.1.3.1.1 Advances In Biodegradable Devices for Pediatric Cardiology
      4.1.3.1.2 Asia-Pacific Region Presents Significant Growth Opportunities
      4.1.3.1.3 Robust Growth in the Transcatheter Heart Valves Market
    4.1.3.2 Pediatric Cardiology Imaging
      4.1.3.2.1 Mobile Cath Labs, An Upcoming Opportunity Area
  4.1.4 Challenges
    4.1.4.1 Pediatric Interventional Cardiology Devices
      4.1.4.1.1 Difficulties in Pediatric Clinical Trials
    4.1.4.2 Pediatric Cardiology Imaging
      4.1.4.2.1 High Cost of Pediatric Interventional Cardiology Imaging Devices
      4.1.4.2.2 Survival of Small Players and New Entrants
4.2 Market Share Analysis
  4.2.1 Structural Heart Defect Closure Devices
  4.2.2 Transcatheter Heart Valves

5 PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES

5.1 Introduction
5.2 North America
5.3 Europe
5.4 APAC
5.5 ROW

6 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET

6.1 Introduction
6.2 Heart Defect Closure Devices
  6.2.1 ASD, VSD, & PFO Closure Devices
    6.2.1.1 Atrial Septal Defect (ASD) Closure Devices
    6.2.1.2 Ventricular Septal Defect (VSD) Closure Devices
    6.2.1.3 Patent Foramen Ovale (PFO) Closure Devices
  6.2.2 Patent Ductus Arteriosus (Pda) Closure Devices
  6.2.3 Left Atrial Appendage (Laa) Closure Devices
6.3 Transcatheter Heart Valves
  6.3.1 Transcatheter Pulmonary Valves
  6.3.2 Transcatheter Aortic Valves (TAV)
6.4 Others
  6.4.1 Angioplasty Balloons
  6.4.2 Angioplasty Stents
  6.4.3 Catheters
  6.4.4 Guidewires

7 GEOGRAPHIC ANALYSIS

7.1 Introduction
7.2 Europe
  7.2.1 Germany
  7.2.2 France
  7.2.3 U.K.
  7.2.4 Italy
  7.2.5 Spain
  7.2.6 Roe
7.3 North America
  7.3.1 U.S.
  7.3.2 Canada
7.4 Asia-Pacific (APAC)
7.5 Rest of the World (ROW)

8 COMPETITIVE LANDSCAPE

8.1 Pediatric Interventional Cardiology Imaging Market
  8.1.1 Introduction
  8.1.2 New Product Launches
  8.1.3 Acquisitions
  8.1.4 Agreements
  8.1.5 Expansions
  8.1.6 Approvals
8.2 Pediatric Interventional Cardiology Devices Market
  8.2.1 Introduction
  8.2.2 Acquisitions
  8.2.3 Agreements
  8.2.4 New Product Launches
  8.2.5 Other Developments
  8.2.6 Approvals

9 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)

9.1 Imaging Products Companies
  9.1.1 Ge Healthcare (Subsidiary of General Electric Company)
  9.1.2 Siemens Healthcare (Subsidiary of Siemens AG)
  9.1.3 toshiba Corporation
9.2 Pediatric Interventional Cardiology Device Companies
  9.2.1 Edwards Lifesciences
  9.2.2 Gore Medical (Subsidiary of W.L. Gore & Associates)
  9.2.3 Medtronic, Inc.
  9.2.4 St. Jude Medical
  9.2.5 Abbott Vascular (A Subsidiary of Abbott Laboratories)
  9.2.6 Boston Scientific Corporation
  9.2.7 Cordis Corporation (Subsidiary of Johnson & Johnson)
  9.2.8 Numed, Inc. (Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.)

List Of Tables

LIST OF TABLES

Table 1 Pediatric Interventional Cardiology Devices Market, By Geography, 2011-2018 ($Million)
Table 2 Number of Pediatric Interventional Cardiology Procedures, By Geography, 2012–2018
Table 3 Global Market, By Device Type, 2011–2018 ($Million)
Table 4 Pediatric Interventional Cardiology Devices Market, By Geography, 2011–2018 ($Million)
Table 5 North America: Pediatric Interventional Cardiology Devices Market, By Country, 2011–2018 ($Million)
Table 6 Europe: Pediatric Interventional Cardiology Devices Market, By Country, 2011–2018 ($Million)
Table 7 Heart Defect Closure Devices Market, By Device Type, 2011–2018 ($Million)
Table 8 Heart Defect Closure Devices Market, By Geography, 2011–2018 ($Million)
Table 9 North America: Heart Defect Closure Devices Market, By Country, 2011–2018 ($Million)
Table 10 Europe: Heart Defect Closure Devices Market, By Country, 2011–2018 ($Million)
Table 11 Pediatric ASD, VSD, & PFO Closure Devices Market, By Geography, 2011–2018 ($Million)
Table 12 North America: Pediatric ASD, VSD, & PFO Closure Devices Market, By Country, 2011–2018 ($Million)
Table 13 Europe: Pediatric ASD, VSD, & PFO Closure Devices Market, By Country, 2011–2018 ($Million)
Table 14 Major Atrial Septal Devices
Table 15 Major Ventricular Septal Defect Closure Devices
Table 16 Major Patent Foramen Ovale Closure Devices
Table 17 Major Patent Ductus Arteriosus Closure Devices
Table 18 Pediatric Pda Closure Devices Market, By Geography, 2011–2018 ($Million)
Table 19 North America: Pediatric Pda Closure Devices Market, By Country, 2011–2018 ($Million)
Table 20 Europe: Pediatric Pda Closure Devices Market, By Country, 2011–2018 ($Million)
Table 21 Major Left Atrial Appendage Closure Devices
Table 22 Pediatric Laa Closure Devices Market, By Geography, 2011–2018 ($Million)
Table 23 North America: Pediatric Laa Closure Devices Market, By Country, 2011–2018 ($Million)
Table 24 Europe: Pediatric Laa Closure Devices Market, By Country, 2011–2018 ($Million)
Table 25 Transcatheter Heart Valves Market, By Device Type, 2011–2018 ($Million)
Table 26 Transcatheter Heart Valves Market, By Geography, 2011–2018 ($Million)
Table 27 North America: Transcatheter Heart Valves Market, By Country, 2011–2018 ($Million)
Table 28 Europe: Transcatheter Heart Valves Market, By Country, 2011–2018 ($Million)
Table 29 Major Transcatheter Pulmonary Valve
Table 30 Pediatric Transcatheter Pulmonary Valve Device Market, By Geography, 2011–2018 ($Million)
Table 31 North America: Transcatheter Pulmonary Valves Market, By Country, 2011–2018 ($Million)
Table 32 Europe: Transcatheter Pulmonary Valves Market, By Country, 2011–2018 ($Million)
Table 33 Major Transcatheter Aortic Valves
Table 34 Pediatric Transcatheter Aortic Valve Device Market, By Geography, 2011–2018 ($Million)
Table 35 North America: Transcatheter Aortic Valves Market, By Country, 2011–2018 ($Million)
Table 36 Europe: Transcatheter Aortic Valves Market, By Country, 2011–2018 ($Million)
Table 37 Other Devices Market, By Geography, 2011–2018 ($Million)
Table 38 North America: Other Devices Market, By Country, 2011–2018 ($Million)
Table 39 Europe: Other Devices Market, By Country, 2011–2018 ($Million)
Table 40 Pediatric Interventional Cardiology Devices Market, By Geography, 2011–2018 ($Million)
Table 41 Europe: Market, By Device Type, 2011–2018 ($Million)
Table 42 Germany: Market, By Device Type, 2011–2018 ($Million)
Table 43 France: Market, By Device Type, 2011–2018 ($Million)
Table 44 U.K.: Market, By Device Type, 2011–2018 ($Million)
Table 45 Italy: Market, By Device Type, 2011–2018 ($Million)
Table 46 Spain: Market, By Device Type, 2011–2018 ($Million)
Table 47 Rest of Europe: Market, By Device Type, 2011–2018 ($Million)
Table 48 North America: Market, By Device Type, 2011–2018 ($Million)
Table 49 U.S.: Market, By Device Type, 2011–2018 ($Million)
Table 50 Canada: Market, By Device Type, 2011–2018 ($Million)
Table 51 Asia-Pacific (APAC): Market, By Device Type, 2011–2018 ($Million)
Table 52 ROW: Market, By Device Type, 2011–2018 ($Million)
Table 53 New Product Launch, 2011-2013
Table 54 Acquisitions, 2011-2013
Table 55 Agreements, 2011-2013
Table 56 Expansions, 2011-2013
Table 57 Approvals, 2011-2013
Table 58 Acqusitions, 2011-2013
Table 59 Agreements, 2011-2013
Table 60 New Product Launch, 2011-2013
Table 61 Other Developments, 2011-2013
Table 62 Approvals, 2011-2014
Table 63 General Electric: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 64 General Electric: Total Revenue, By Segment, 2011–2013 ($Million)
Table 65 General Electric: Total Revenue, By Geography, 2011–2013 ($Billion)
Table 66 Siemens Healthcare: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 67 Siemens Healthcare: Total Revenue, By Segment, 2011–2013 ($Million)
Table 68 Siemens Healthcare: Total Revenue, By Geography, 2011–2013 ($Million)
Table 69 Toshiba Corporation: Total Revenue and R&D Expenditure, 2011–2013 ($Billion)
Table 70 Toshiba Corporation: Total Revenue, By Segment, 2011–2013 ($Billion)
Table 71 Toshiba Corporation: Total Revenue, By Geography, 2011–2013 ($Billion)
Table 72 Edwards Lifesciences: Total Revenue and R&D Expenditure, 2010–2012 ($Million)
Table 73 Edwards Lifesciences: Total Revenue, By Segment, 2010–2012 ($Million)
Table 74 Edwards Lifesciences: Total Revenue, By Geography, 2010–2012 ($Million)
Table 75 Medtronic, Inc.: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 76 Medtronic, Inc.: Total Revenue, By Segment, 2011–2013 ($Million)
Table 77 Medtronic, Inc.: Total Revenue, By Geography, 2011–2013 ($Million)
Table 78 St. Jude Medical: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 79 St. Jude Medical: Total Revenue, By Segment, 2011–2013 ($Million)
Table 80 St. Jude Medical: Total Revenue, By Geography, 2011–2013 ($Million)
Table 81 Abbott Laboratories: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 82 Abbott Laboratories: Total Revenue, By Segment, 2011–2013 ($Million)
Table 83 Abbott Laboratories: Total Revenue, By Geography, 2011–2013 ($Million)
Table 84 Boston Scientific Corporation: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
Table 85 Boston Scientific Corporation: Total Revenue, By Segment, 2011–2013 ($Million)
Table 86 Boston Scientific Corporation: Total Revenue, By Geography, 2011–2013 ($Million)
Table 87 Johnson & Johnson: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 88 Johnson & Johnson: Total Revenue, By Segment, 2011–2013 ($Million)
Table 89 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Segment, 2011–2013 ($Million)
Table 90 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Geography, 2011–2013 ($Million)

About

The  APAC  region  accounted  for  the  highest  number  of  pediatric  interventional  cardiology procedures in 2012. In 2012, around XX to XX pediatric interventional cardiology procedures were performed in the region. This high number of procedures can be attributed to the large pediatric  population  and  the  high  prevalence  of  congenital  heart  defects  in  this  region.  The relaxation in the one-child policy in China and the improving healthcare infrastructure in the region  are  factors  that  are  also  likely  to  increase  the  number  of  procedures  further  in  the coming five years. 

The global structural heart defect closure devices market is dominated by two major players, namely, St. Jude Medical, Inc. (U.S.) and W.L Gore & Associates, Inc. (U.S.), which together accounted for XX% of the structural heart defect closure devices market in 2012.

The  North  American  region  includes  the  U.S.  and  Canada.  The  number  of  pediatric interventional  cardiology  procedures  in  the  North  American  region  is  poised  to  grow  at  a healthy  CAGR  of  XX%  from  2012  to  2018.  This  is  a  well-developed  region  in  terms  of  an established  healthcare  infrastructure,  availability  of  advanced  health  technologies,  and widespread health insurance coverage. Moreover, there are various cardiology and pediatric associations in the region that are actively working towards the betterment of children with congenital  heart  diseases.  For  instance,  the  American  Heart  Association  released  a  revised scientific  statement—Indications  for  Cardiac  Catheterization  and  Intervention  in  Pediatric Cardiac   Disease—in   2011.   This   statement   provides   recommendations   to   healthcare professionals for performing various cardiac catheterization and interventional procedures on pediatric  patients.  Such  guidelines  help  to  improve  the  procedure  outcomes,  thereby enhancing the overall quality of care.

The European market commanded the largest share of XX% in 2013. This market was valued at an estimated $XX million in 2013 and is expected to reach $XX million by 2018, at a CAGR of  XX%  from  2013  to  2018.  This  large  share  of  the  European  market  can  be  attributed  to increasing venture capitalist investments, various government initiatives to improve pediatric care, and the favorable regulatory environment in the region. The APAC market, on the other hand, is poised to grow at the highest CAGR of XX% to reach $XX million by 2018 from $XX million  in  2013.  The  growth  of  the  APAC  market  can  be  attributed  to  improving  healthcare facilities in this region and the increasing number of collaborations between foreign companies and  local  players.  Furthermore,  various  prominent  players  are  investing  in  APAC  countries, which is a major factor driving the growth of this market.